News
$97M Series D backed by strategic investors across the oncology ecosystem positions Thyme Care to break through cancer care’s biggest bottlenecks
Thyme Care, the leading value-based cancer care enabler, today announced a $97M Series D fundraise from current investors CVS Health® Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures.
RevSpring to acquire Kyruus Health, creating a connected care journey from search to final payment
RevSpring, a Frazier Healthcare portfolio company, is pleased to announce that it has entered into a definitive agreement to acquire Kyruus Health, a pioneer in provider data, search, and scheduling.
Truven acquires Springbuk to help employers make better, faster healthcare decisions
Truven by Merative, a leading portfolio of healthcare analytics and real-world data solutions, has acquired Springbuk, a leading health intelligence platform for employers and their advisors.
Strive Health raises $550 Million in Series D funding
Strive Health, the national leader in value-based kidney care, raised $300 million in a Series D equity round and secured $250 million in debt financing for a combined $550 million capital raise.
EVERSANA merges with Waltz Health to create a new force in pharma commercialization and prescription drug access
EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access.
DispatchHealth and Medically Home merger closes, creating a national platform for complex care at home
DispatchHealth today announced the close of its merger with Medically Home, bringing together two industry leaders to form one of the nation’s most comprehensive and established health care platforms focused on delivering complex care at home.
Quantum Health signs agreement to acquire Embold Health
Quantum Health, the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health, a leading physician-led healthcare technology company.
Echo CEO Rob Coppedge named to Duke-Margolis Capital Impact Council
Echo Health Ventures CEO Rob Coppedge is honored to be a member of the Duke-Margolis Capital Impact Council, designed to to strengthen alignment of private investment with measurable improvements in health and health care.
Echo Health Ventures announces two strategic advisors and a key promotion
Echo Health Ventures is thrilled to announce the addition of two advisors to our team, and a key promotion.
DispatchHealth and Medically Home to merge, increasing access to hospital-level care at home for Americans
DispatchHealth and Medically Home today announced they have entered into a definitive agreement to merge, creating the country’s most comprehensive provider of advanced medical care at home.
Global Corporate Venturing honors Echo’s Suzanne McLemore and Annie Weissbach
Global Corporate Venturing this week honored two Echo Health Ventures leaders: Suzanne McLemore, Managing Partner and Head of Echo Health Advisors; and Annie Weissbach, Senior Associate on the Strategic Investment team.
Echo Health Ventures named to Inc.’s 2024 list of Founder-Friendly Investors
Echo Health Ventures was just named to Inc.’s sixth annual Founder-Friendly Investors list, honoring the private equity, venture capital firms, and lenders with a track record of backing founder-led companies.